Remarkably, although the downregulation of miR-320 in CFs by rAAV9-FSP1-miR-320-TUD could slightly increase fibrosis, it could not aggravate cardiac hypertrophy and dysfunction in TAC mice (Fig. 4). This evidence concerns the gene S100A4 and cardiac hypertrophy.